Verge Genomics uses machine learning and human genomics to accelerate drug discovery.
Verge Genomics's investors include Alumni Ventures, Draper Associates, Eli Lilly, BlackRock, Basis Set Ventures.
Verge Genomics is headquartered in San Francisco, United States.
Verge Genomics uses machine learning and human genomics to accelerate drug discovery.
Verge Genomics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Verge Genomics — Funding & Investors." VCBacked, October 2, 2024, https://www.vcbacked.co/company/verge-genomics. Accessed October 26, 2026.
VCBacked. (2024). Verge Genomics — Funding & Investors. Retrieved October 26, 2026, from https://www.vcbacked.co/company/verge-genomics
{{cite web |title=Verge Genomics — Funding & Investors |url=https://www.vcbacked.co/company/verge-genomics |website=VCBacked |access-date=October 26, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated